Evidence suggests that sporadic diffuse gastric cancer may develop from an “alternative” carcinogenetic pathway (i.e., alternative to the dysplasia-invasive carcinoma pathway of Lauren intestinal type) in the context of atrophic/metaplastic gastritis triggered by CDH1 loss of function [23]. The gene discussed is CDH1; the disease is dysplasia.